XT-I serum activity

1. Postmenopausal osteoporosis decreases XT-I serum activity in humans.

   “Serum XT-I activity was significantly reduced in postmenopausal osteoporosis patients, whereas XT-II activity remained unchanged.”

   Humanspostmenopausal osteoporosis vs healthy controlsserumfemalesn = 40

   Xylosyltransferase-I serum activity is a promising biomarker for postmenopausal osteoporosis

   Scientific reports·20 Aug 2026

More on Postmenopausal osteoporosis

1. XT-I serum activity is associated with FRAX in humans.

   “XT-I showed strong positive correlations with all BMD parameters and significant negative correlations with FRAX and bone turnover markers.”

   Humansserumfemales

   Xylosyltransferase-I serum activity is a promising biomarker for postmenopausal osteoporosis

   Scientific reports·20 Aug 2026

More on FRAX

1. XT-I serum activity is associated with BMD in humans.

   “XT-I showed strong positive correlations with all BMD parameters and significant negative correlations with FRAX and bone turnover markers.”

   Humansserumfemales

   Xylosyltransferase-I serum activity is a promising biomarker for postmenopausal osteoporosis

   Scientific reports·20 Aug 2026

More on BMD